PEDIATRIC INGESTIONS - CHARCOAL ALONE VERSUS IPECAC AND CHARCOAL

被引:45
作者
KORNBERG, AE
DOLGIN, J
机构
[1] Division of Emergency Medicine, Children's Hospital of Buffalo, State University of New York at Buffalo, NY
[2] Western New York Poison Center, Children's Hospital of Buffalo, State University of New York at Buffalo, NY
关键词
activated charcoal; poisoning; pediatric; syrup of ipecac;
D O I
10.1016/S0196-0644(05)82385-6
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Study objectives: To determine the effect of syrup of ipecac (SOI) on time to receive and retention of activated charcoal (AC) and on total ED time. Design: During a two-year period, patients were enrolled in a prospective, randomized, unblinded, controlled trial. Setting: All patients were recruited and studied in a pediatric emergency department. Participants: Seventy children less than 6 years old (mean age, 2.4 +/- 0.2 years) who presented with mild-to-moderate acute oral ingestions. Interventions: Group 1 received SOI before AC. Group 2 received only AC. Measurements and main results: Group 1 patients took significantly longer to receive AC than group 2 from the time of ED arrival (2.6 +/- 0.1 vs 0.9 +/- 0.1 hours, P < .0001). Group 1 children were significantly more likely to vomit AC than were group 2 children (18 of 32 vs six of 38, P < .001). Patients receiving SOI who were subsequently discharged spent significantly more time in the ED than those receiving only AC (4.1 +/- 0.2 vs 3.4 +/- 0.2 hours, P < .05). Conclusions: Ipecac delays the administration of AC, hinders its retention, and prolongs ED time in pediatric ingestion patients. These data support the recommendation that AC alone should be the gastrointestinal decontamination method of choice for the mild-to-moderate pediatric ingestion patient presenting to an ED.
引用
收藏
页码:648 / 651
页数:4
相关论文
共 14 条
[1]  
Neuvonen, Variainen, Tokola, Comparison of activated charcoal and ipecac syrup in prevention of drug absorption, Eur J Clin Pharmacol, 24, pp. 557-562, (1983)
[2]  
Tenenbein, Cohen, Sitar, Efficacy of ipecac-induced emesis, orogastric lavage, and activated charcoal for acute drug overdose, Ann Emerg Med, 16, pp. 838-841, (1987)
[3]  
Curtis, Barone, Giacona, Efficacy of ipecac and activated charcoal/cathartic: Prevention of salicylate absorption in a simulated overdose, Arch Intern Med, 22, pp. 103-114, (1984)
[4]  
Tenenbein, Inefficacy of gastric emptying procedures, J Emerg Med, 3, pp. 133-136, (1985)
[5]  
Danel, Henry, Glucksman, Activated charcoal, emesis, and gastric lavage in aspirin overdose, Br Med J, 296, (1988)
[6]  
McNamara, Aaron, Gemborys, Et al., Efficacy of charcoal cathartic versus ipecac in reducing serum acetaminophen in a simulated overdose, Ann Emerg Med, 18, pp. 934-938, (1989)
[7]  
Kulig, Bar-Or, Cantrill, Et al., Management of acutely poisoned patients without gastric emptying, Ann Emerg Med, 14, pp. 562-567, (1985)
[8]  
Albertson, Derlet, Foulke, Et al., Superiority of activated charcoal alone compared with ipecac and activated charcoal in the treatment of acute toxic ingestions, Ann Emerg Med, 18, pp. 56-59, (1989)
[9]  
Park, Spector, Goldberg, Et al., Expanded role of charcoal therapy in the poisoned and overdosed patient, Arch Intern Med, 146, pp. 969-973, (1986)
[10]  
Neuvonen, Olkkola, Oral activated charcoal in the treatment of intoxications, Med Toxicol, 3, pp. 33-58, (1988)